Hovione shortlisted for the CPhI Pharma Awards 2023!
DCAT Week 2023
Learn how Hovione can support your projects and the production of your much needed medicines and breakthrough therapies.
You might be interested in:
|Continuous tableting is suited for all types of drug products for oral delivery, and allows for leaner and risk-reduced development paths, leaner supply chains, increased built-in quality, and more flexible and less complex manufacturing processes. Meet our team and find out why The future is continuous.|
Dispersome® technology enables the formulation of API with a novel protein-based excipient, developing ASDs with high solubility and bioavailability which can be manufactured at a large-scale using Spray Drying. If you are developing a novel drug formulation or need to improve your drug candidate, speak with our team.